ratherproject.com
RATHER Project
http://www.ratherproject.com/index.php
RATHER is a consortium project funded by the European Commission's. 7th Framework Programme of Research and Development. The project focuses on several key aspects of breast cancer research, and involves the combined efforts of six universities and two biomedical companies. RATHER commenced in January 2011, and will operate for a period of six years. The RATHER consortium are investigating two specific difficult-to-treat subtypes of breast cancer. Invasive Lobular Carcinoma (ILC). The disease, as opposed...
mammaprint.com.au
Agendia | Breast Cancer Diagnosis Treatment
http://www.mammaprint.com.au/agendia
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo.
mammaprint.com.au
Agendia’s MammaPrint & BluePrint Test | Breast Cancer Diagnosis Treatment
http://www.mammaprint.com.au/agendias-mammaprint-blueprint-test
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. Agendia’s Bl...
mammaprint.co.nz
Patient Eligibility | Breast Cancer Diagnosis Treatment
http://www.mammaprint.co.nz/patients-eligibility
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Address: 277 B...
mammaprint.co.nz
Test Results | Breast Cancer Diagnosis Treatment
http://www.mammaprint.co.nz/test-results
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. A Low Risk Mam...
mammaprint.com.au
Test Results | Breast Cancer Diagnosis Treatment
http://www.mammaprint.com.au/test-results
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. A Low Risk M...
mammaprint.com.au
Targeted Breast Cancer Medical Treatment Now A Reality – MINDACT is Out! | Breast Cancer Diagnosis Treatment
http://www.mammaprint.com.au/targeted-breast-cancer-medical-treatment-now-a-reality-mindact-is-out
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. MSAC – MammaPrint DAP. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. Http:/ www&#...
mammaprint.co.nz
About MammaPrint | Breast Cancer Diagnosis Treatment
http://www.mammaprint.co.nz/about-mammaprint
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test.
mammaprint.co.nz
Tested and approved | Breast Cancer Diagnosis Treatment
http://www.mammaprint.co.nz/tested-and-approved
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. This was a mys...
mammaprint.co.nz
Agendia Genomic Tests | Breast Cancer Diagnosis Treatment
http://www.mammaprint.co.nz/agendia-genomic-tests
Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Profile Pricing and Payment. Breast cancer patients could be. Spared chemotherapy with new. Genetic test, study shows. Targeted Breast Cancer Medical. Treatment Now A Reality. Breast Cancer Subgroup Unlikely. To Benefit From Adjuvant Chemo. 038; BluePrint Test. Agendia’s Blue...
SOCIAL ENGAGEMENT